MX9305566A - Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. - Google Patents
Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion.Info
- Publication number
- MX9305566A MX9305566A MX9305566A MX9305566A MX9305566A MX 9305566 A MX9305566 A MX 9305566A MX 9305566 A MX9305566 A MX 9305566A MX 9305566 A MX9305566 A MX 9305566A MX 9305566 A MX9305566 A MX 9305566A
- Authority
- MX
- Mexico
- Prior art keywords
- procedures
- compounds
- preparation
- derivatives
- cyclics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
El invento concierne a derivados de urea cíclicos de la fórmula general en que Ra, Rb, X e Y están definidos como en la reivindicación 1, a sus tautómeros, sus estereoisómeros y sus sales, en particular sus sales fisiológicamente compatibles con ácidos o bases inorgánicos u orgánicos que presentan valiosas propiedades farmacológicas, preferiblemente efectos inhibidores de la agregación, a medicamentos que contienen los compuestos y a procedimientos para su preparación.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4230470A DE4230470A1 (de) | 1992-09-11 | 1992-09-11 | Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
DE19934302052 DE4302052A1 (de) | 1992-09-11 | 1993-01-26 | Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
DE19934309213 DE4309213A1 (de) | 1992-09-11 | 1993-03-22 | Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9305566A true MX9305566A (es) | 1994-05-31 |
Family
ID=27204203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9305566A MX9305566A (es) | 1992-09-11 | 1993-09-10 | Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. |
Country Status (16)
Country | Link |
---|---|
US (2) | US5681841A (es) |
EP (1) | EP0587134A3 (es) |
JP (1) | JPH06263740A (es) |
KR (1) | KR940007023A (es) |
AU (1) | AU4624993A (es) |
BG (1) | BG98103A (es) |
CA (1) | CA2105934A1 (es) |
CZ (1) | CZ188193A3 (es) |
FI (1) | FI933942A (es) |
HU (1) | HUT71496A (es) |
IL (1) | IL106955A0 (es) |
MX (1) | MX9305566A (es) |
NO (1) | NO933248L (es) |
NZ (1) | NZ248633A (es) |
PL (1) | PL300347A1 (es) |
SK (1) | SK94393A3 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
DE4407961A1 (de) * | 1994-03-10 | 1995-09-14 | Thomae Gmbh Dr K | Imidazolidin-2-one, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
ZA963391B (en) * | 1995-05-24 | 1997-10-29 | Du Pont Merck Pharma | Isoxazoline fibrinogen receptor antagonists. |
WO1997002245A1 (fr) * | 1995-07-06 | 1997-01-23 | Japan Tobacco Inc. | Derives de benzamidoxime et leur utilisation a des fins medicinales |
ZA966885B (en) * | 1995-08-22 | 1998-02-16 | Du Pont Merck Pharma | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors. |
US5925635A (en) * | 1996-04-17 | 1999-07-20 | Dupont Pharmaceuticals Company | N-(amidinophenyl) cyclourea analogs as factor XA inhibitors |
ES2218677T3 (es) * | 1996-04-17 | 2004-11-16 | Bristol-Myers Squibb Pharma Company | Derivados de n-(amidinofenil)-n'-(subst.)-3h-2,4-benzodiazepin-3-ona como inhibidores del factor xa. |
ATE266636T1 (de) * | 1997-09-09 | 2004-05-15 | Bristol Myers Squibb Pharma Co | Benzimidazolinone, benzoxazolinone, benzopiperazinone, indanone und deren derivate als faktor xa inhibitoren |
WO2001032639A1 (en) | 1999-11-04 | 2001-05-10 | Ortho-Mcneil Pharmaceutical, Inc. | Nonpeptide substituted benzothiazepines as vasopressin antagonists |
US6964974B2 (en) * | 2000-09-08 | 2005-11-15 | Hoffmann-La Roche Inc. | 2,3-oxidosqualene-lanosterol cyclase inhibitors |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
US7291603B2 (en) * | 2002-07-24 | 2007-11-06 | Ptc Therapeutics, Inc. | Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
US7241787B2 (en) * | 2004-01-25 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
US7598267B2 (en) * | 2004-05-13 | 2009-10-06 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
EP1621535A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
JP2009520688A (ja) * | 2005-11-23 | 2009-05-28 | エピックス デラウェア, インコーポレイテッド | S1p受容体調節化合物およびそれらの使用 |
US7919519B2 (en) * | 2005-11-23 | 2011-04-05 | Epix Pharmaceuticals Inc. | S1P receptor modulating compounds and use thereof |
CA2646469A1 (en) * | 2006-03-21 | 2007-09-27 | Epix Delaware, Inc. | S1p receptor modulating compounds |
DE102006024024A1 (de) * | 2006-05-23 | 2007-11-29 | Bayer Healthcare Aktiengesellschaft | Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung |
KR20090021223A (ko) | 2006-06-20 | 2009-02-27 | 와이어쓰 | 이미다졸리디논 kv1.5 칼륨 채널 억제제 |
CL2007003590A1 (es) * | 2006-12-12 | 2008-02-29 | Wyeth Corp | Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt |
MX2010002885A (es) * | 2007-09-20 | 2010-04-01 | Amgen Inc | Derivados de acido 1-(4-(bencilbenzamido)-bencil)-azetidin-3-carbo xilico y compuestos relacionados como moduladores de receptores de s1p para el tratamiento de trastornos inmunitarios. |
TW201024283A (en) * | 2008-12-01 | 2010-07-01 | Targacept Inc | Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine |
DE102008060967A1 (de) | 2008-12-06 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylsulfonyltriazolone und ihre Verwendung |
DE102009013642A1 (de) | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylalaninderivate und deren Verwendung |
DE102010001064A1 (de) | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung |
DE102009028929A1 (de) | 2009-08-27 | 2011-07-07 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Heterocyclisch-substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung |
LT2539326T (lt) | 2010-02-27 | 2017-08-10 | Bayer Intellectual Property Gmbh | Sujungti bisariliniai ariltriazolonai ir jų panaudojimas |
DE102010040187A1 (de) | 2010-09-02 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte N-Phenethyl-triazolonacetamide und ihre Verwendung |
DE102010040924A1 (de) | 2010-09-16 | 2012-03-22 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung |
EP3008056B8 (en) * | 2013-06-11 | 2021-03-03 | Receptos Llc | Novel glp-1 receptor modulators |
KR101957178B1 (ko) * | 2014-04-28 | 2019-03-12 | 지앙수 카니온 파마수티컬 씨오., 엘티디. | 항엔테로바이러스71 티아디아졸리딘 유도체 |
WO2015184222A1 (en) * | 2014-05-30 | 2015-12-03 | Southern Research Institute | Inhibitors of hepatocyte growth factor [hgf] and macrophage stimulating protein [msp] maturation |
JP6623220B2 (ja) | 2014-11-03 | 2019-12-18 | バイエル ファーマ アクチエンゲゼルシャフト | ヒドロキシアルキル置換フェニルトリアゾール誘導体およびその使用 |
US9988367B2 (en) | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
EP3886853A4 (en) | 2018-11-30 | 2022-07-06 | Nuvation Bio Inc. | DIARYLHYDANTOI COMPOUNDS AND METHODS OF USE THEREOF |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1394708A (fr) * | 1962-10-19 | 1965-04-09 | American Cyanamid Co | Procédé de préparation d'imidazolidinones et imidazolidinethiones substituées |
FR1516714A (fr) * | 1962-11-07 | 1968-02-05 | Bayer Ag | Procédé de préparation de dérivés de l'imidazolidine |
IL24005A (en) * | 1964-12-31 | 1970-05-21 | Robins Co Inc A H | 1,3-disubstituted-4-(2-substituted-ethyl)-2-imidazolidinones,processes for their production and pharmaceutical compositions containing them |
NL6709697A (es) * | 1966-07-16 | 1968-01-17 | ||
US4744813A (en) * | 1986-11-24 | 1988-05-17 | Stauffer Chemical Co. | Herbicidal imidazolidine-2-ones and methods of use |
NZ233502A (en) * | 1989-06-09 | 1991-11-26 | Janssen Pharmaceutica Nv | 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions |
GB9106571D0 (en) * | 1991-03-27 | 1991-05-15 | Erba Carlo Spa | Derivatives of substituted imidazol-2-one and process for their preparation |
WO1992000282A1 (en) * | 1990-06-29 | 1992-01-09 | The Upjohn Company | Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity |
DK286990D0 (da) * | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
DE4107857A1 (de) * | 1991-03-12 | 1992-09-17 | Thomae Gmbh Dr K | Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
-
1993
- 1993-09-06 SK SK943-93A patent/SK94393A3/sk unknown
- 1993-09-08 EP EP19930114401 patent/EP0587134A3/de not_active Withdrawn
- 1993-09-09 IL IL106955A patent/IL106955A0/xx unknown
- 1993-09-09 BG BG98103A patent/BG98103A/bg unknown
- 1993-09-09 FI FI933942A patent/FI933942A/fi not_active Application Discontinuation
- 1993-09-10 MX MX9305566A patent/MX9305566A/es not_active IP Right Cessation
- 1993-09-10 NZ NZ248633A patent/NZ248633A/en unknown
- 1993-09-10 PL PL93300347A patent/PL300347A1/xx unknown
- 1993-09-10 CZ CZ931881A patent/CZ188193A3/cs unknown
- 1993-09-10 AU AU46249/93A patent/AU4624993A/en not_active Abandoned
- 1993-09-10 US US08/120,008 patent/US5681841A/en not_active Expired - Fee Related
- 1993-09-10 HU HU9302577A patent/HUT71496A/hu unknown
- 1993-09-10 CA CA002105934A patent/CA2105934A1/en not_active Abandoned
- 1993-09-10 NO NO933248A patent/NO933248L/no unknown
- 1993-09-11 KR KR1019930018293A patent/KR940007023A/ko not_active Application Discontinuation
- 1993-09-13 JP JP5226864A patent/JPH06263740A/ja active Pending
-
1997
- 1997-05-28 US US08/864,528 patent/US5880284A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI933942A0 (fi) | 1993-09-09 |
AU4624993A (en) | 1994-03-24 |
BG98103A (bg) | 1994-07-15 |
US5681841A (en) | 1997-10-28 |
NO933248D0 (no) | 1993-09-10 |
NZ248633A (en) | 1995-08-28 |
CZ188193A3 (en) | 1994-11-16 |
HU9302577D0 (en) | 1993-11-29 |
CA2105934A1 (en) | 1994-03-12 |
EP0587134A2 (de) | 1994-03-16 |
HUT71496A (en) | 1995-11-28 |
NO933248L (no) | 1994-03-14 |
IL106955A0 (en) | 1993-12-28 |
PL300347A1 (en) | 1994-05-16 |
FI933942A (fi) | 1994-03-12 |
SK94393A3 (en) | 1994-08-10 |
KR940007023A (ko) | 1994-04-26 |
EP0587134A3 (en) | 1994-07-06 |
JPH06263740A (ja) | 1994-09-20 |
US5880284A (en) | 1999-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9305566A (es) | Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
MX9306303A (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
MX9307781A (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
MX9303466A (es) | Derivados de bifenilo, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
MX9203677A (es) | Derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
MX9200269A (es) | Derivados de bifenilo, medicamentos que contienen estos compuestos y procedimientos para su preparacion | |
MX9302448A (es) | Derivados iminicos ciclicos, procedimientos para su preparacion y medicamentos que contienen estos compuestos. | |
UY26513A1 (es) | Nuevas piperidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparación. | |
AR006569A1 (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion | |
AR022906A1 (es) | Amidas de aminoacidos modificadas, medicamentos que contienen estos compuestos y procedimiento para su preparacion | |
UY26903A1 (es) | Heterociclos bicíclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparación | |
PA8548001A1 (es) | Derivados aromaticos de acidos dicarboxilicos | |
ES2054860T5 (es) | Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos. | |
MX9300014A (es) | Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion. | |
AR022939A1 (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion | |
ES2161290T3 (es) | Derivados de quinazolina. | |
ES2186961T3 (es) | Derivados de acido benzazepinona-n-acetico sustituidos por acido fosfonico, asi como procedimiento para su preparacion y medicamentos que contienen estos compuestos. | |
MX9302459A (es) | Derivados imino ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
AR021843A1 (es) | Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion. | |
MX9302034A (es) | Bencidazoles, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
MX9304424A (es) | Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
TR199801082T2 (xx) | Fosfonokarbiksilik asitlerin yeni fosfolipid t�revleri, bunlar�n �retimi, bunun yan�s�ra bunlar�n antiviral farmas�tik maddeler olarak kullan�m�. | |
UY26501A1 (es) | Derivados de piperazina sustituidos, su preparación y su empleo como medicamentos | |
AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
ES2164869T3 (es) | Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |